Shawn Aaron
机构: Ottawa Hospital Research Institute, University of Ottawa
每年引用次数
引用次数
引用: 22,465
H-指数: 80
I10-指数 : 208
出版物: 537
Multiple combination bactericidal testing of multidrug resistant Pseudomonas aeruginosa isolates from the sputa of Australian cystic fibrosis patients in aerobic, anaerobic and biofilm modes of growth
A. Pajkos , M. Elkins , P. Bye , S. Aaron
18th Annual North American Cystic Fibrosis Conference 38 291 -291
2004
Comparison of Antibiotic-Only and Antibiotic-Steroid Combination Treatment in Corneal Ulcer Patients: A Double-Blinded, Randomized Clinical Trial - Interim Report
S. Al-Ghambdi , R. Balabanian , D. Fergusson , W. B. Jackson
Investigative Ophthalmology & Visual Science 48 ( 13) 4275 -4275
1
2007
Ten‐year trends in direct costs of asthma: a population‐based study
H. Tavakoli , J. M. FitzGerald , W. Chen , L. Lynd
Allergy 72 ( 2) 291 -299
12
2017
Voluntary and automatic recruitment of superficial and deep abdominal muscles in adults with and without cystic fibrosis
A. Taillon-Hobson , S. Aaron , L. McLean , M. Bilodeau
Journal of Electromyography and Kinesiology 21 ( 3) 411 -417
2
2011
WS17.6 Phase 3 trial of inhaled levofloxacin (Aeroquin™, MP-376, APT-1026) vs. tobramycin inhalation solution (TIS) in intensively treated CF patients over 6 months
J.S. Elborn , D. Geller , D. Conrad , S. Aaron
Journal of Cystic Fibrosis 12 ( 12)
11
2013
Transient cough-induced blindness in temporal arteritis
S. Kwong , A. Daniel , S. Kalra , S. Houston
Neurology 67 ( 8) 1520 -1520
2006
Prescription Pathways from Initial Medication Use to Triple Therapy in Oder Individuals with COPD: A Real-World Population Study
T. Stukel , T. Kendzerska , S.D. Aaron , A.S. Gershon
TP15. TP015 UPDATES IN ADHERENCE AND TREATMENT OF LUNG DISEASE
2021
Investigating the Clinical Utility of Individualized Risk Prediction for Preventing Acute Exacerbations of Chronic Obstructive Pulmonary Disease
M.A. Puhan , M. Sadatsafavi , A.S. Gershon , A. Safari
TP41. TP041 DIAGNOSIS AND RISK ASSESSMENT IN COPD
2021
Comparative Effectiveness of Triple Therapy versus Dual Bronchodilation in Elder Adults with Chronic Obstructive Pulmonary Disease (COPD): A Real-World Population Study
T. Stukel , T. Kendzerska , S.D. Aaron , A.S. Gershon
TP15. TP015 UPDATES IN ADHERENCE AND TREATMENT OF LUNG DISEASE
2021
Assessment of Airway Inflammation and Hyperresponsiveness in Subjects with Respiratory Symptoms and Normal Spirometry
K. Vandemheen , M. FitzGerald , D. Lougheed , C. Bergeron
TP10. TP010 CLINICAL AND POPULATION-LEVEL STUDIES OF ASTHMA
2021
Involvement of Patients and Professionals in the Development of a Conceptual Framework on Functional Health Literacy to Improve Chronic Airways Disease Outcomes
I. Poureslami , J. Shum , L.-P. Boulet , C. Poirier
C35. HEALTH SERVICES RESEARCH IN COUGH, CF, AND ILD
2019
Lost in translation? How adults living with Cystic Fibrosis understand treatment recommendations from their healthcare providers, and the impact on adherence to therapy
S. Pakhale , J. Baron , M. Armstrong , G. Tasca
Patient Education and Counseling 99 ( 8) 1319 -1324
6
2016
Trends in COPD Prevalence, Incidence and Health Services Use in Younger Adults
AS Gershon , R McGihon , J Luo , T Kendzerska
D102. OPTIMIZING OUTCOMES IN COPD
1
2019
A threshold regression model for recurrent exacerbations in chronic obstructive pulmonary disease.
S.D. Aaron , T. Ramsay , K. Vandemheen , G.A. Whitmore
Journal of Clinical Epidemiology 63 ( 12) 1324 -1331
12
2010
Participation, Characteristics, and Outcomes of a Population-Based Study: The Canadian Cohort Obstructive Lung Disease (CanCOLD)
J. Bourbeau , D. Doiron , S. Biswas , W.C. Tan
C23. ASSESSMENT OF OUTCOME RISK IN OBSTRUCTIVE LUNG DISEASE
2020
The Heterogeneity of Prevalence and Risk Factors for Chronic Obstructive Pulmonary Disease (COPD) in the Canadian Urban Population: Results from the Canadian Obstructive Lung Disease (COLD) Study
C. Leung , J. Bourbeau , D. Sin , S.D. Aaron
C23. ASSESSMENT OF OUTCOME RISK IN OBSTRUCTIVE LUNG DISEASE
2020
Comparison of Chronic Obstructive Pulmonary Disease Risk Profiles in Younger, Middle-Aged and Older Adults: A Population-Based Study
A.S. Gershon , R.E. McGihon , P. Prequeno , T. Kendzerska
C34. CHRONIC AND ACUTE MANAGEMENT AND RESOURCE UTILIZATION FOR COPD
2020
The implementation of rifapentine and isoniazid (3HP) in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP study.
G. G. Alvarez , D. Van Dyk , R. Mallick , S. Lesperance
International Journal of Circumpolar Health 79 ( 1) 1758501
2
2020
Spirometry in the primary care setting: Influence on clinical diagnosis and management of airflow obstruction: Chest 2005;128:2443–7
R.E. Dales , K.L. Vandemheen , J. Clinch , S.D. Aaron
Respiratory Medicine: Copd Update 1 ( 4) 137
15
2006
Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA.
J. Bourbeau , S.D. Aaron , N.C. Barnes , K.J. Davis
Respiratory Medicine 123 94 -97
8
2017